Grounded in science, elevating the standard

Jason Ackerman was appointed to the TerrAscend Board of Directors and named to the role of Executive Chairman in November 2019. Jason is the founder of FreshDirect, a pure-play home delivery grocer that pioneered e-commerce in the US, defining a unique and profitable operating model that is customer-centric, hyper-fresh, focused on relationships with producers, and technologically innovative. Over 20 years he served various senior roles including President, CFO and CEO & Chairman. More recently in 2016, Jason also founded Foodkick, where he designed and assembled a team to build a new same-day hourly service. Jason has deep knowledge of retail e-commerce, especially in online grocery strategy and logistics across the spectrum of pure-play to brick-and-mortar retailers. He has strong experience operationalizing strategy – be it with org structure & talent, technology vision, or go-to market (marketing and product development). Jason is also experienced in operations and logistics topics, including design networks, picking methods (and related technologies) and last mile delivery. He is a consumer centric thinker and firmly believes in metric-driven management. He is a Senior Advisor at The Boston Consulting Group and actively involved in digital transformation and strategies.

Mr. Stauffer has over 25 years of experience as a business executive holding various senior finance and leadership roles across multiple industries. Most recently, Mr. Stauffer served as Senior Vice President of Finance and Chief Financial Officer of the Global Consumer Beauty Division at Coty, Inc. Prior to his role at Coty, Mr. Stauffer spent 10 years at The Hershey Company holding various senior financial positions, including  Vice President of Finance and Chief Financial Officer for Hershey’s International business, leading Corporate FP&A and Internal Audit. Prior to Hershey, Mr. Stauffer held various finance positions, both domestically and internationally, at Dell Technologies and Procter & Gamble.

Jason has more than two decades of legal experience and over a decade of global experience. He has served in a variety of functions for multi-national companies in life sciences, including biotechnology, pharmaceuticals, consumer health, and medical devices.

Most recently, Mr. Marks served as the Chief Legal Officer, General Counsel & Corporate Secretary of InflaRx N.V., a publicly traded biotechnology company. In this role, he was a member of the executive management team responsible for all aspects of legal, compliance, and corporate governance, as well as driving key business and strategic initiatives. Mr. Marks was also responsible for the operations of the company’s U.S. subsidiary.

Prior to his role at InflaRx, Mr. Marks was SVP, Head of Legal Branded Rx (Salix) and Global Litigation & Government Investigations, at Bausch Health, where he managed some of the highest-profile matters in life sciences, was the lead lawyer for Salix, a $2B division of Bausch Health, and created and led the company’s first Legal Operations and Enterprise Risk Management functions. Mr. Marks also held senior roles at Novartis’s Alcon division, including the head of legal for North America and at Stryker Corporation. Mr. Marks received a J.D. from The George Washington University School of Law and an A.B. in History from The University of Chicago.

Joanna has over 12 years of human resources, operational execution and strategic leadership experience within retail and manufacturing sectors. She has worked extensively with investment professionals of private equity in leading change management in M & As, execution of multi-faceted strategic growth, talent acquisition, policies and governance. A strong partner, who values the importance of the individual as well the team fostering development through strong, meaningful strategies.

Jason Ackerman was appointed to the TerrAscend Board of Directors and named to the role of Executive Chairman in November 2019. Jason is the founder of FreshDirect, a pure-play home delivery grocer that pioneered e-commerce in the US, defining a unique and profitable operating model that is customer-centric, hyper-fresh, focused on relationships with producers, and technologically innovative. Over 20 years he served various senior roles including President, CFO and CEO & Chairman. More recently in 2016, Jason also founded Foodkick, where he designed and assembled a team to build a new same-day hourly service. Jason has deep knowledge of retail e-commerce, especially in online grocery strategy and logistics across the spectrum of pure-play to brick-and-mortar retailers. He has strong experience operationalizing strategy – be it with org structure & talent, technology vision, or go-to market (marketing and product development). Jason is also experienced in operations and logistics topics, including design networks, picking methods (and related technologies) and last mile delivery. He is a consumer centric thinker and firmly believes in metric-driven management. He is a Senior Advisor at The Boston Consulting Group and actively involved in digital transformation and strategies.

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC, and the advisor for five investment partnerships with over $2 billion in assets under management. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the healthcare sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy. Mr. Wild is the Chairman of the Board of TerrAscend Corp. and Arbor Pharmaceuticals. He is a board member of Vensun Pharmaceuticals and Vitruvias Therapeutics. Funds managed by JW Asset Management, LLC are the largest shareholders in TerrAscend Corp. Mr. Wild is also a board member of NETA NJ LLC where he will be actively involved in planning and directing the organization’s strategic and long-range goals.

Richard Mavrinac held positions as CFO for George Weston Limited and Executive VP of Loblaw Companies and has extensive expertise in public company finance and strategy.

Craig Collard is the CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patient and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, Mr. Collard was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.

Lisa has 20+ years of experience in manufacturing, distribution, and retail, previously holding senior financial positions with some of Canada’s largest publicly-traded corporations. A strategic thinker with diverse experience in leading growth, Lisa has advised mid-market privately held companies in both the United States and Canada. Lisa holds a BA (Economics) from Western University, and an MBA from Queen’s University, and also holds the Institute of Corporate Directors ICD.D (Certified Director) designation.

Ed Schutter is a seasoned executive with over thirty years of pharmaceutical industry experience. He currently serves as Chief Executive Officer of Arbor Pharmaceuticals (“Arbor”), an Atlanta, Georgia based specialty pharmaceutical company which markets prescription products for the cardiovascular, neuroscience and orphan/hospital markets. Arbor also has several branded prescription products in late stage development. Prior to joining Arbor, Mr. Schutter served as President of Sciele (Shionogi) Pharmaceuticals. Prior to Sciele, he served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He has also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Mr. Schutter is a registered pharmacist with a degree in Pharmaceutical Sciences from Mercer University and an MBA from Kennesaw State University. He is currently a board member of Arbor, Vitruvias Therapeutics, and Establishment Labs (ESTA) and has been a previous board member of other public, private and non profit organizations.